Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Platform: GPL16417 | Other | TAB | |||||
GSE120164 |
Genome-wide CRISPR-Cas9 interrogation of splicing networks reveals a mechanism for recognition of autism-misregulated neuronal microexons [SPAR-seq]
|
|
48 |
|
Ulrich Braunschweig | Oct 12, 2018 | ||
GSE184432 |
Scalable Production of Mouse Erythroid Cells using an in vitro Embryoid Body differentiation System [Capture-C]
|
|
12 |
|
Mira Tony Kassouf | Sep 22, 2021 | ||
GSE184435 |
Scalable Production of Mouse Erythroid Cells using an in vitro Embryoid Body differentiation System
|
42 |
|
Mira Tony Kassouf | Sep 22, 2021 | |||
GSE211233 |
Multipartite super-enhancers function in an orientation-dependent manner [Capture-C]
|
|
48 |
|
Mira Tony Kassouf | Aug 18, 2022 | ||
GSE211238 |
Multipartite super-enhancers function in an orientation-dependent manner
|
93 |
|
Mira Tony Kassouf | Aug 18, 2022 | |||
GSE192765 |
Kinetics of Tbet+ B cells during LCMV infection
|
9 | Alexander Lemenze | Jan 27, 2022 | ||||
GSE246586 |
SPLICER: A Highly Efficient Base Editing Toolbox That Enables in vivo Exon Skipping For Targeting Alzheimer’s Disease [miSeq]
|
|
177 |
|
Pablo Pinera | Dec 10, 2023 | ||
GSE246588 |
SPLICER: A Highly Efficient Base Editing Toolbox That Enables in vivo Exon Skipping For Targeting Alzheimer’s Disease
|
183 | Pablo Pinera | Dec 10, 2023 | ||||
GSE183344 |
Role of EXO1 nuclease activity in genome maintenance, the immune response and tumor suppression in Exo1D173A mice
|
|
18 |
|
SERGIO ROA | Jul 11, 2022 | ||
GSE84589 |
Cis-regulatory landscape of four cell types of the retina
|
64 |
|
Dirk Schuebeler | Oct 25, 2017 | |||
GSE116704 |
CG dinucleotides enhance promoter activity independent of DNA methylation
|
186 |
|
Dirk Schuebeler | Jan 20, 2019 | |||
GSE165776 |
Next Generation Sequencing Identifies Biased Light Chain Usage and Evidence of Light Chain Gene Replacement in phosphatidylcholine (PtC)-specific CD5+ B cells from dnRAG1 and VH12 mice.
|
|
60 |
|
Patrick Swanson | Jun 01, 2022 |